Boomerang Ventures has led a $2.6 million seed funding round for Lizzy Care, a health tech company offering an AI-powered platform for at-home dementia and memory care. The investment will help Lizzy Care expand its technology platform that combines predictive analytics, real-time care coordination, and local care management to make high-quality dementia care more accessible.
This funding is particularly significant in addressing a major women’s health challenge, as women account for approximately two-thirds of all dementia cases globally. With women’s longer life expectancy and biological differences that may increase vulnerability to Alzheimer’s disease, solutions like Lizzy Care’s platform could have an outsized impact on women’s health outcomes.
“Dementia care today is fragmented and reactive, leaving families struggling to navigate complex care decisions,” said Dr. Marc Rothman, CEO of Lizzy Care. “At Lizzy Care, we’re addressing this challenge head-on with an intuitive platform that empowers caregivers, enhances communication, and ensures families experience the joy and comfort they deserve, by focusing on enhancing the quality of life for their loved ones. Boomerang Ventures’ investment will be instrumental in expanding our platform, advancing product development, and accelerating our impact in key markets.”
The Lizzy Care platform features a mobile app that enables families and care teams to stay connected with real-time updates on patient status, predictive analytics to anticipate needs, local care management for coordinating personalized care, secure messaging, and HIPAA-compliant data security. The company’s clinical oversight is led by geriatrics experts, and it is integrated with clinical practices to deliver the new CMS GUIDE program for comprehensive memory care services.
“The demand for dementia care is skyrocketing as the population ages and conditions like Alzheimer’s become more common. In 2023, the global dementia treatment market was valued at about $17 billion and is expected to keep growing at nearly 8% a year through 2030,” said Oscar Moralez, Founder & Managing Partner at Boomerang Ventures. “At Boomerang, we don’t just invest in technology-we invest in exceptional leadership and expertise. At the core of every investment decision we make is a solid, experienced team. We are confident in Lizzy Care’s seasoned team, led by Dr. Marc Rothman. His extensive expertise in geriatric medicine, home-based care, and healthcare business strategy positions them to transform at-home dementia and memory care. Their approach will ensure care is more accessible, effective, and proactive, exactly when it’s needed most.”
Research has shown that women experience dementia differently than men. Women exhibit more amyloid plaques and brain shrinkage earlier in life, and hormonal changes associated with menopause may play a role in increasing vulnerability to Alzheimer’s disease. Additionally, certain genetic factors may have a stronger association with Alzheimer’s risk in women than in men. These biological differences, combined with traditional caregiving roles that often fall to women in families, make dementia a particularly pressing women’s health issue.
The new funding will help Lizzy Care enhance service delivery, expand sales and clinical resources, advance product development, prepare for Medicare Readiness in 2025, and expand geographically into new U.S. regions including New York, the Tri-State area, North Florida, Kentucky, and Indiana. The company also plans to launch partnerships with clinical sites and value-based healthcare organizations.
“As a company dedicated to connected health innovation, we recognize the urgent need for better dementia care solutions,” said Moralez. “Lizzy Care is at the forefront of this transformation, delivering an AI-powered, personalized approach that aligns perfectly with our focuses on aging, chronic care, and at-home care. We are excited to partner with Lizzy Care as they scale their impact and redefine dementia care for families nationwide.”
